Azenta, Inc.

Azenta, Inc.

AZTAยทNASDAQ

$23.89

+2.0%
HealthcareMedical - Instruments & Supplies

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

At a Glance

Live Snapshot
Market Cap$1.10B
EPS-1.2200
P/E Ratio-19.58
Earnings Date08/04/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

Medium confidence

Valuation multiple is compressed (P/E -19.6).

Valuation inputs: P/E -19.6, earnings yield N/A, momentum +2.0%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE -3.2%, ROIC +2.1%).

Profitability stack: net margin -9.4%, ROE -3.2%, ROIC +2.1%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +16.1%, momentum +2.0%, net margin -9.4%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

azta

Azenta, Inc. Market vs Earnings Trajectory

AZTA ยท NASDAQ

Loading price and EPS data...

Azenta, Inc.

Azenta, Inc. Fair Value Envelope

AZTA ยท NASDAQ

Our analysis suggests that AZTA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $23.89, this represents a potential HIDDEN relative to our calculated worth for Azenta, Inc..

Intrinsic Value
Current Price: $23.89
3Y+713.0%
5Y-239.0%
10Y+20.0%
3Y+7.0%
5Y-34.0%
10Y+6.0%
3Y-87.0%
5Y-186.0%
10Y-20.0%
3Y-115.0%
5Y+91.0%
10Y+83.0%
3Y-107.0%
5Y-1962.0%
10Y+44.0%
3Y-45.0%
5Y+32.0%
10Y+200.0%
Azenta, Inc.

Azenta, Inc. Profit Bridge

AZTA ยท NASDAQ
Revenue593.82M
Cost of Goods Sold (323.54M)
Gross Profit270.28M
Operating Expenses (281.55M)
Operating Income-11.27M
Interest Expense (0.00)
Other Income/Expense4.12M
Pretax Income-7.14M
Income Tax (-31.60M)
Net Income-55.76M
Net Income
-55.76M

Profitability Analysis

Gross Margin

45.5%

Strong gross margins indicate healthy pricing and efficient production or service delivery.

Operating Margin

-1.9%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-9.4%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

45.52%
Gross Profit Margin
3%
3Y+10.0%
5Y+7.0%
10Y+29.0%
-1.90%
Operating Profit Margin
-64%
3Y-56.0%
5Y-122.0%
10Y-351.0%
-9.39%
Net Profit Margin
-67%
3Y-88.0%
5Y-230.0%
10Y-24.0%
-3.23%
Return on Equity
-65%
3Y-75.0%
5Y-160.0%
10Y-74.0%
-2.71%
Return on Assets
-66%
3Y-77.0%
5Y-165.0%
10Y-73.0%
2.11%
Return on Invested Capital
-234%
3Y-406.0%
5Y-58.0%
10Y-115.0%
AZTA

Azenta, Inc. Cash Conversion Engine

AZTA ยท NASDAQ
Net Income-55.76M
Depreciation & Amortization61.21M
Stock-Based Compensation20.88M
Change in Working Capital-22.84M
Others95.73M
Capital Expenditures-33.86M
Free Cash Flow38.32M

Cash Flow Quality Analysis

FCF Conversion Rate

-68.7%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

46.9%

Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.

FCF Growth Trend

+210.3%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$22.84M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

azta

Azenta, Inc. Funding & Solvency Profile

AZTA ยท NASDAQ
Cash & Cash Equivalents234.03M
Net Receivables131.32M
Inventory78.51M
Other Current Assets136.64M
Total Current Assets727 M
Property, Plant & Equipment231.28M
Goodwill & Intangible Assets644.50M
Long-Term Investments0.00
Other Non-Current Assets300.62M
Total Non-Current Assets532 M
Total Assets
1.90B

Financial Health Analysis

Current Ratio

2.83x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.22x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

470 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

38% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

azta

Azenta, Inc. Street Expectations Map

AZTA ยท NASDAQ

Wall Street analysts project that AZTA stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 44.50, with estimates ranging from a low of 44.00 to a high of 45.00.

Lowest Target
44.00
84.18%
Consensus Target
44.50
86.27%
Highest Target
45.00
88.36%

The consensus 1-year price target stands at 44.50, with estimates ranging from a low of 44.00 to a high of 45.00.

Analyst Consensus Analysis

Upside Potential

+86.3%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

2.2% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

azta

Azenta, Inc. Insider Positioning

AZTA ยท NASDAQ

During the last 12 months, insiders have purchased $234K and sold $133K worth of AZTA shares, resulting in $101K of net buying activity.

3 Months

Bought

10.0K

163.80K

Sold

0

0.00

Net Activity

+164K

+$164K

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

316

9.29K

Net Activity

-9K

-$9K

9-12 Months

Bought

2.5K

69.90K

Sold

4.3K

123.86K

Net Activity

-54K

-$54K

Top Buyers

1
CWL

Cornog William L

Director

10.0K sharesโ€ข1 transactions

$164K

2
LLY

Lin Lawrence Y.

Officer: Evp, Cfo And Treasurer

2.5K sharesโ€ข1 transactions

$70K

Top Sellers

1
ZG

Zhou Ginger

Officer: Svp And Gm, Multiomics

2.2K sharesโ€ข2 transactions

$62K

2
PO

Pirogova Olga

Officer: Svp And Chro

2.2K sharesโ€ข2 transactions

$62K

3
MJ

Marotta John

Director, Officer: President And Ceo

316 sharesโ€ข1 transactions

$9K

Insider Activity Analysis

Net Insider Sentiment

Bullish

Moderately bullish with $101K net buying. Insiders show cautious optimism through measured share purchases.

Buy/Sell Ratio

1.76:1

Positive buy/sell ratio. Buying exceeds or matches selling, indicating net positive insider sentiment.

Recent Trend (3 Months)

$164K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

Moderate Selling

3 insider sellers vs. 2 buyers. More insiders selling than buying suggests cautious or negative sentiment.

Insider Activity Insight

Sustained buying momentum: Consistent net buying over multiple quarters suggests insiders maintain conviction in the company's prospects. This is particularly meaningful if buying continued through market volatility.

0.00%
Dividend Yield
3Y-
5Y-100.0%
10Y-100.0%
ย 

azta Dividend History

AZTA
10Y CAGR +2%
Latest $0.1
Annual $0.5
5 year growth trend
Last Period: +0%